Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Q Zhang, R Xiang, S Huo, Y Zhou, S Jiang… - Signal transduction and …, 2021 - nature.com
The pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in an unprecedented setback …

The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19

FK Yoshimoto - The protein journal, 2020 - Springer
The devastating effects of the recent global pandemic (termed COVID-19 for “coronavirus
disease 2019”) caused by the severe acute respiratory syndrome coronavirus-2 (SARS CoV …

Racial disparities-associated COVID-19 mortality among minority populations in the US

DJ Alcendor - Journal of clinical medicine, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a betacoronavirus that
causes the novel coronavirus disease 2019 (COVID-19), is highly transmissible and …

Extra-respiratory manifestations of COVID-19

CC Lai, WC Ko, PI Lee, SS Jean, PR Hsueh - International journal of …, 2020 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has become a global health threat. Although most …

Microstructure optimization of bioderived polyester nanofilms for antibiotic desalination via nanofiltration

Y Bai, B Liu, J Li, M Li, Z Yao, L Dong, D Rao… - Science …, 2023 - science.org
The successful implementation of thin-film composite membranes (TFCM) for challenging
solute-solute separations in the pharmaceutical industry requires a fine control over the …

Potential clinical benefits of quercetin in the early stage of COVID-19: results of a second, pilot, randomized, controlled and open-label clinical trial

F Di Pierro, S Iqtadar, A Khan… - … journal of general …, 2021 - Taylor & Francis
Background The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
cause of the ongoing global pandemic known as COVID-19. Based on the potential antiviral …

Herbal immune-boosters: Substantial warriors of pandemic Covid-19 battle

K Khanna, SK Kohli, R Kaur, A Bhardwaj, V Bhardwaj… - Phytomedicine, 2021 - Elsevier
Current scenario depicts that world has been clenched by COVID-19 pandemic. Inevitably,
public health and safety measures could be undertaken in order to dwindle the infection …

Coronavirus disease (COVID-19): Current status and prospects for drug and vaccine development

K Ita - Archives of medical research, 2021 - Elsevier
The Coronavirus disease 2019 (COVID-19) pandemic has spread to almost all nooks and
corners of the world. There are numerous potential approaches to pharmacologically fight …

Small molecules in the treatment of COVID-19

S Lei, X Chen, J Wu, X Duan, K Men - Signal transduction and targeted …, 2022 - nature.com
The outbreak of COVID-19 has become a global crisis, and brought severe disruptions to
societies and economies. Until now, effective therapeutics against COVID-19 are in high …

A review of potential suggested drugs for coronavirus disease (COVID-19) treatment

P Tarighi, S Eftekhari, M Chizari, M Sabernavaei… - European Journal of …, 2021 - Elsevier
The latest pandemic, coronavirus disease-2019 (COVID-19), is associated with high
prevalence and easy transmission, which is expanding globally with no conventional …